AstraZeneca plc (LSE:AZN) has begun trading its ordinary shares on theNew York Stock Exchange(NYSE) from 2 February 2026, marking a change in the company’s global listing arrangements. With this move, AstraZeneca’s ordinary shares are now traded across the NYSE, theLondon Stock Exchange(LSE) and Nasdaq …
AstraZeneca PLC (LSE:AZN) has entered into a strategic collaboration agreement with CSPC Pharmaceuticals to advance the development of next-generation therapies targeting obesity and type 2 diabetes (T2D). The agreement covers eight development programmes, including one clinical-ready asset and multiple preclinical candidates.
Kooth PLC (LSE:KOO), a provider of digital mental health services, has announced a trading update for the financial year ended 31 December 2025. The update details revenue performance, contract wins in the US, and operational progress in California and the UK, while outlining expectations …
AstraZeneca plc (LSE:AZN) remains firmly in the spotlight after receiving a fresh endorsement from Rothschild & Co Redburn, even as its share price edges closer to broader market expectations. The stock closed at GBX 14,020.00 on 16 January, marginally lower on the day, but …
Cardiogeni plc (LSE:CGNI), a biotechnology company developing cell-based therapies for heart failure, released its unaudited interim results for the six-month period ended 30 September 2025. The reported figures include previously disclosed audited results for the twelve months ended 31 March 2025.
Genflow Biosciences Plc (LSE:GENF), a biotechnology company developing gene therapies targeting healthspan, has completed the dosing phase of its ongoing canine trial. All enrolled dogs received the full administration of the investigational SIRT6-based therapy. During this phase, no adverse events were reported, and no …
Spire Healthcare Group plc (LSE:SPI) has provided a trading update for the period ending 31 October 2025, alongside revised outlooks for the fiscal years 2025 and 2026. The Group also announced an extension of its GBP 425 million banking facilities to August 2028. Despite …
Polarean Imaging plc (LSE:POLX), a medical imaging technology company focused on functional MRI of the lungs, has announced the installation of its first Xenon MRI research system in Taiwan. The system will be delivered to the National Taiwan University Hospital (NTUH), recognized as the …
OptiBiotix Health plc (LSE:OPTI), a life sciences business developing products to reduce hunger, support gut microbiome health, and provide sugar alternatives, has received its first order from a well-known European weight management company. The low six-figure order includes private label SlimBiome® finished products—gummies, bars, …
Abingdon Health plc (LSE:ABDX) has secured a new contract with an expected value of approximately USD 2m. The agreement, structured as a Master Service Agreement (MSA) with a US-based company, covers the development, scale-up, and technical transfer of a semi-quantitative, multiplex lateral flow test …